http://www.fpnotebook.com/
Male-patterned BaldnessAka: Androgenetic Alopecia, Androgenic Alopecia
- Definition
- Non-scarring androgen related Alopecia
- Epidemiology
- Most common type of Alopecia
- Hereditary trait
- Course
- Hair Loss onset between ages 12 to 40 years
- Hair Loss evident by age 50 in >50% of patients
- Pathophysiology
- Androgen exposure shortens Hair Follicle Anagen phase
- Men with increased androgen levels
- Women with increased 5a-reductase, androgen receptors
- Affected hair becomes shorter, finer, less pigmented
- Progresses with each successive cycle
- Related to higher Dihydrotestosterone (DHT) levels
- Metabolite of testosterone
- Symptoms
- Gradual progression of Hair Loss
- Signs
- Men
- Hair Loss affecting temples and crown
- Sides and back are spared
- Women
- Central and frontal scalp thinning
- Temples are spared unlike the M-Type found in men
- Class: Rating of Hair Loss (Norwood and Hamilton Scale)
- Type I: Minimal hair line recession
- Type II: Symmetrical triangular Hair Loss over temples
- Type III: More Hair Loss at vertex and less at temple
- Type IV-V: Temple and vertex Hair Loss; some crown loss
- Type VI: Contiguous frontal, vertex, and crown baldness
- Type VII: Hair remains only over ears and occiput
- References
- Hamilton (1951) Ann NY Acad Dermatol 53:708-28
- Norwood (1975) South Med J 68(11):1359
- Labs: Women with Androgenetic Alopecia
- Indications (Not required in most cases)
- Irregular Menses
- Sudden Hair Loss
- Hirsutism
- New onset Acne Vulgaris
- Infertility
- Lab tests
- Total Testosterone
- Free Testosterone
- Dehydroepiandrosterone sulfate (DHEA-S)
- Prolactin
- Management
- Medications for women
- Minoxidil (Rogaine) 2%
- Applied topically twice daily to dry scalp
- Risk of Hypertrichosis of the face
- Retin-A may augment effect (experimental)
- Apply at different time of day
- Oral Contraceptives
- Less effective than Minoxidil
- Choose OCP with low Progestin Androgenic Activity
- Norgestimate (e.g. Ortho Tri-Cyclen)
- Norethindrone (e.g. Modicon)
- Spironolactone
- Variable efficacy
- Medications for men
- Finasteride (Propecia)
- Indicated for men only
- Oral preparation for vertex or frontal balding
- Longterm use risks high grade Prostate Cancer
- Thompson (2003) N Engl J Med 349:215
- Minoxidil (Rogaine 5%)
- Most effective for vertex balding
- Applied topically twice daily to dry scalp
- Hair Transplant
- Looks better in photos
- Better in curly haired persons
- References
- Drake (1996) J Am Acad Dermatol 35:465
- Scow (1999) Am Fam Physician 59(8):2189
- Springer (2003) Am Fam Physician 68(1):93
Navigation Tree